JOINT CorpJYNT

NasdaqFinancePatent Owners & Lessors
Price (close)
$8.29
Market cap
$117.7M
P/E
31.0x
Revenue (TTM)
$58.5M
Net income
$3.8M
Dividend yield
—
1-year total return
-15.8%
Net margin
6.5%
Revenue growth
-17.8%
Debt / equity
—

What JOINT Corp does.

We are a growing franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. We seek to be the leading provider of chiropractic care in the markets we serve and to become the most recognized brand in our industry. We delivered over 14.4 million patient visits in 2025, down from 14.7 million patient visits in 2024, generating over $532.4 million and $530.3 million of system-wide sales, respectively, across our highly franchised network. We will continue the franchise-focused expansion of chiropractic clinics in key markets throughout North America and potentially abroad. We strive to accomplish our mission by making quality care readily available and affordable in a retail setting. We have created a growing network of modern, consumer-friendly chiropractic clinics operated or managed by franchisees and by us that employ licensed chiropractors. Our model enables us to price our services below most competitors’ pricing for similar services and below most insurance co-payment levels (i.e., below the patient co-payment required for an insurance-covered service).

Since acquiring the predecessor to our company in March 2010, we have grown our enterprise from eight to 960 clinics in operation as of December 31, 2025, with an additional 82 franchise licenses sold but not yet developed across our network, and 57 letters of intent for 57 future clinic licenses. As of December 31, 2025, our franchisees owned or managed 885 clinics, and we owned or managed 75 clinics. Our future growth strategy will focus on accelerating the development of our franchise base through the sale of additional franchises and through the continued support of our regional developer network. We collect a royalty of 7.0% of gross sales from franchised clinics. We remit a 3.0% royalty to our regional developers on the gross sales of franchises opened within certain regional developer protected territories. We also collect a national marketing fee of 2.0% of gross sales of all franchised clinics. We receive an initial franchise fee of $39,900 for each franchise we sell directly and offer a veterans discount, as well as a $10,000 per license discount for franchisees who purchase multiple location franchises. For each franchise sold through our network of regional developers, the regional developer typically receives up to 50% of the respective franchise fee.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$58.7M$80.0M$101.3M$117.7M$52.2M$54.9M
Net income$13.2M$7.6M$626,705-$9.8M-$5.8M$2.9M
Free cash flow$8.0M$6.9M$2.3M$9.7M$8.2M$334,724

More on JYNT.

Figures from JOINT Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.